Nyxoah Archives | Page 2 of 11 | Be Korea-savvy
Nyxoah to Participate in the Piper Sandler 35th Annual Healthcare Conference

Nyxoah to Participate in the Piper Sandler 35th Annual Healthcare Conference

Nyxoah to Participate in the Piper Sandler 35th Annual Healthcare Conference Mont-Saint-Guibert, Belgium, Nov. 21 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Piper Sandler [...]

Nyxoah Reports Third Quarter 2023 Financial and Operating Results

Nyxoah Reports Third Quarter 2023 Financial and Operating Results

Nyxoah Reports Third Quarter 2023 Financial and Operating Results Partners with ResMed Germany to increase OSA awareness and therapy penetration Mont-Saint-Guibert, Belgium, Nov. 8 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today [...]

Nyxoah to Participate in the Jefferies London Healthcare Conference

Nyxoah to Participate in the Jefferies London Healthcare Conference

Mont-Saint-Guibert, Belgium, Nov. 7 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Jefferies London Healthcare Conference, which takes place November 14 – 16, 2023 [...]

Nyxoah to Release Third Quarter 2023 Financial Results on November 8, 2023

Nyxoah to Release Third Quarter 2023 Financial Results on November 8, 2023

Nyxoah to Release Third Quarter 2023 Financial Results on November 8, 2023 Mont-Saint-Guibert, Belgium, Oct. 26 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for [...]

Nyxoah to Participate in the Cantor Fitzgerald Global Healthcare Conference

Nyxoah to Participate in the Cantor Fitzgerald Global Healthcare Conference

Mont-Saint-Guibert, Belgium, Sept. 13 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Cantor Fitzgerald Global Healthcare Conference, which takes place September 26 – 28, 2023 [...]

Nyxoah to Participate in Upcoming Investor Conferences

Nyxoah to Participate in Upcoming Investor Conferences

Mont-Saint-Guibert, Belgium, Sept. 5 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in two upcoming investor conferences in New York City. Olivier Taelman, Nyxoah’s Chief Executive Officer, will deliver [...]

Information on the Total Number of Voting Rights and Shares

Information on the Total Number of Voting Rights and Shares

Mont-Saint-Guibert (Belgium), Aug. 30 (Korea Bizwire) – In accordance with article  15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares. Share capital: EUR 4,925,869.05 Total number of securities carrying voting rights: 28,673,985 (all ordinary shares) Total number of [...]

Nyxoah Reports Second Quarter and First Half 2023 Financial and Operating Results

Nyxoah Reports Second Quarter and First Half 2023 Financial and Operating Results

Mont-Saint-Guibert, Belgium, Aug. 8, (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today reported financial and operating results for the second quarter and first half of 2023. Recent Financial and Operating Highlights Presented 12-month efficacy data1 on the [...]

Nyxoah to Release Second Quarter 2023 Financial Results on August 8, 2023

Nyxoah to Release Second Quarter 2023 Financial Results on August 8, 2023

Mont-Saint-Guibert, Belgium, July 27 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the second quarter of 2023 on Tuesday, August 8, 2023, after market close. Company management [...]

Publication Relating to a Transparency Notification

Publication Relating to a Transparency Notification

Mont-Saint-Guibert (Belgium), July 27 (Korea Bizwire) – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a rectification of an earlier transparency notification. On July 25, 2023, Nyxoah received the rectification of the April 16, 2023 transparency notification that it had received [...]